Professor Garth Cruickshank
Click here to find out more
At The Brain Tumour Charity we recognise that nurses and allied healthcare professionals are at the frontline when it comes to the care and rehabilitation offered to brain tumour patients. This work is necessary and highly valued.
That is why by organising the Nurse and AHP study day our aim is to support the professionals supporting brain tumour patients through their journey. At this CPD accredited event, attendees will get the opportunity to be informed by leading clinicians and researchers about the latest developments in brain tumour treatment and care. Furthermore, they will have the opportunity during the day and at the drinks reception afterwards, to network with colleagues from across the UK in a relaxed and welcoming environment.
Date: Friday 19th May 2017
Time: Registration 09.00 – 09.30, End of Sessions at 17:15, Drinks reception to follow
Venue: The Birmingham Conference &Events Centre, Hill Street, Birmingham, B5 4EW
Please note, places are limited and there is currently an Early Bird discounted price of £30 per person. Group bookings of 3 or more will get a reduced price of £25 per person. (*book by 19 April for these discounted fees)
Trained at the Royal Free Hospital and Institute of Neurological Sciences Glasgow. Moved to Chair in Neurosurgery in Birmingham, 1997.
Instrumental in driving the NICE IOG (2006) for improving Outcomes in Patients with Brain Tumours that has gone a long way to improving the service nationwide and the recognition of the special nature of brain tumour patients.
He has been heavily involved in delivering clinical trials at all phases and has recently completed the IDEB study using drug loaded beads to deliver new agents intra-tumourally to patients with recurrent glioblastoma (Phase 1).As well as being involved with specialised commissioning for many
Jon is a consultant in palliative medicine and clinical lead for the Central & North West London NHSFT palliative care service; he leads on the provision of palliative care at the National Hospital for Neurology & Neurosurgery, UCLH, London.His interests include people with neurological and neuro-oncological disease, non-cancer respiratory disease, ethics and law encompassing advance care planning, and psycho-spiritual care. He practices mindfulness-based meditation.
Olaf Ansorge trained in medicine at the Universities of Göttingen, Freiburg and Lausanne. He came to the UK on a Fellowship in Neurology and Neuropathology and completed training as a Neuropathologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London.In 2002 he became a Consultant Neuropathologist in Oxford with a special interest in gliomas and pituitary tumours. Current projects include linking new brain imaging techniques with neuropathology and developing tissue banking strategies for clinical research.
Michael Jenkinson sub-specialises in neurosurgical oncology including awake craniotomy, intraventricular/pineal tumours and stereotactic radiosurgery.
He sits in the NCRI brain tumour clinical studies group and the chairs the meningioma and metastasis subgroup, as well as being a member of the Society of British Neurological Surgeons academic committee, and associate editor of the British Journal of Neurosurgery.His research interests include cerebral metastases and meningoma, and clinical studies on quality of life in brain tumours. He is the recipient of grants for basic science and clinical research from the MRC and NIHR including as chief investigator for the international, multi-centre ROAM trial (Radiation versus Observation following surgical resection of Atypical Meningioma) and co-chief investigator on the BASICS trial (The British Antibiotic and Silver Impregnated Catheters for ventriculoperitoneal Shunts randomized controlled trial).
After graduating with a BSc in Genetics from the University of Edinburgh, Dr. Rahman completed a PhD in Molecular Biology at the Roslin Institute, Edinburgh under the supervision of Sir Ian Wilmut in 2007. He joined Professor Richard Grundy's laboratory at the Children's Brain Tumour Research Centre, University of Nottingham as a Post-Doctoral Research Associate in 2007. Upon receiving the Nottingham Advanced Research Fellowship for the Faculty of Medicine in 2011,
Dr. Rahman initiated two complementary research programmes – biomaterials to deliver drugs to the brain and 3-dimensional brain tumour culture.
He was awarded the British Neuro-Oncology Society Young Investigator of the Year in 2014, the highest United Kingdom accolade for a researcher under the age of 35.
Dr. Rahman was appointed Assistant Professor at the University of Nottingham's new School of Medicine in October 2013 where he continues to lead research programmes in the biological understanding and treatment of high grade gliomas. He is currently the Deputy Chair of the international Children's Brain Tumour Drug Delivery Consortium.
Ally is a senior psychiatric trainee with an interest in the psychiatric consequences of brain tumours. His postgraduate M.D. (2011) was on the topic "Depression in glioma."
He has since authored numerous papers and written chapters on the psychiatric consequences of brain tumours for two major psychiatric textbooks. He is based in Edinburgh.
David qualified in 1999 and first worked on the Adult Leukaemia Unit at the
In 2012 David moved back to The Christie to become the Teenage Cancer Trust Lead Nurse for TYA's for Greater Manchester, Cheshire, Lancashire and Cumbria region. This current role has the same remit as the previous lead nurse post but comes with the challenges of a much bigger area, different hospital configuration and a very different TYA team. David was part of the Teenage Cancer Trust Nursing and Support Pilot - Bridging the Gap, that won the Nursing Times inaugural HRH The Prince of Wales Award for Integrated Approaches to Care.
David is involved in various different national groups, including being the treasurer for Teenagers and Young Adults with Cancer (TYAC) and has been a Clinical Lead for an NHS Improving Quality workstream that was looking at end of treatment issues for TYA's.
Feedback from the 2016 event
“The various sessions complemented one another in a useful way. I now feel far more informed and able to deal with my patients more effectively."
“Really enjoyed the day – holistic approach with nurses and AHPs. Great way to network with other professionals, hear new ideas and ways of working."